1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East and Africa Multiple Sclerosis Therapeutics Market – By Drug Class

1.3.2        Middle East and Africa Multiple Sclerosis Therapeutics Market – By Route Of Administration

1.3.3        Middle East and Africa Multiple Sclerosis Therapeutics Market – By Distribution Channel

1.3.4        Middle East and Africa Multiple Sclerosis Therapeutics Market – By Country

2.           Multiple Sclerosis Therapeutics Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Middle East and Africa Multiple Sclerosis Therapeutics– Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Middle East and Africa (MEA) – PEST Analysis

4.2.2        Expert Opinions

5.           Multiple Sclerosis Therapeutics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Prevalence of Multiple Sclerosis (MS)

5.1.2        Rising Funding for Multiple Sclerosis Research

5.2         Market Restraints

5.2.1        High Cost of Multiple Sclerosis Treatment

5.3         Market Opportunities

5.3.1        Increasing Awareness About Multiple Sclerosis

5.4         Future Trends

5.4.1        Development and Launch of Innovative Products

5.5         Impact analysis

6.           Multiple Sclerosis Therapeutics Market – Middle East and Africa Analysis

6.1         Middle East and Africa Multiple Sclerosis Therapeutics Market Revenue Forecast and Analysis

7.           Multiple Sclerosis Therapeutics Market Analysis – By Drug Class

7.1         Overview

7.2         Multiple Sclerosis Therapeutics Market Revenue Share, by Drug Class (2019 and 2027)

7.3         Immunosuppressant

7.3.1        Overview

7.3.2        Immunosuppressant: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Immunomodulators

7.4.1        Overview

7.4.2        Immunomodulators: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.           Multiple Sclerosis Therapeutics Market Analysis – By Route of Administration

8.1         Overview

8.2         Multiple Sclerosis Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)

8.3         Injectable

8.3.1        Overview

8.3.2        Injectable: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Oral

8.4.1        Overview

8.4.2        Oral: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

9.           Multiple Sclerosis Therapeutics Market Analysis – By Distribution Channel

9.1         Overview

9.2         Multiple Sclerosis Therapeutics Market Share, by Distribution Channel, 2019 and 2027

9.3         Hospital Pharmacies

9.3.1        Overview

9.3.2        Hospital Pharmacies: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

9.4         Retail Pharmacies

9.4.1        Overview

9.4.2        Retail Pharmacies: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

9.5         E-Commerce

9.5.1        Overview

9.5.2        E-Commerce: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

10.        Multiple Sclerosis Therapeutics Market Analysis and Forecast To 2027 – Middle East and Africa Analysis

10.1      Middle East and Africa Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027

10.1.1     Overview

10.1.2     Middle East and Africa Multiple Sclerosis Therapeutics Market Share, By Country (2019 & 2027) (%)

10.1.3     Saudi Arabia Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.3.1       Saudi Arabia Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.3.2       Saudi Arabia Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)

10.1.3.3       Saudi Arabia Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027, By Route of Administration (US$ Mn)

10.1.3.4       Saudi Arabia Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)

10.1.4     South Africa Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027

10.1.4.1       South Africa Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.4.2       South Africa Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)

10.1.4.3       South Africa Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027, By Route of Administration (US$ Mn)

10.1.4.4       South Africa Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027, By Distribution Channel US$ Mn)

10.1.5     UAE Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027

10.1.5.1       UAE Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.5.2       UAE Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)

10.1.5.3       UAE Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027, By Route of Administration (US$ Mn)

10.1.5.4       UAE Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)

10.1.5.5       Rest of Middle East and Africa: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.        Impact of COVID-19 Pandemic on Middle East and Africa Multiple Sclerosis Therapeutics Market

11.1      Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Merck & Co., Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Novartis AG

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Bayer AG

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Sanofi

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Bristol-Myers Squibb Company

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      TEVA PHARMACEUTICAL INDUSTRIES LTD

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      F. HOFFMANN-LA ROCHE LTD.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Biogen

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Saudi Arabia Multiple Sclerosis Therapeutic Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)

Table 2.             Saudi Arabia Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Route of Administration (US$ Mn)

Table 3.             Saudi Arabia Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 4.             South Africa Multiple Sclerosis Therapeutic Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)

Table 5.             South Africa Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Route of Administration (US$ Mn)

Table 6.             South Africa Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 7.             UAE Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)

Table 8.             UAE Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Route of Administration (US$ Mn)

Table 9.             UAE Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

Table 13.          Organic Developments Done By Companies

Table 14.          Inorganic Developments Done By Companies

Table 15.          Glossary of Terms, Multiple sclerosis therapeutics Market

LIST OF FIGURES

Figure 1.           Multiple Sclerosis Therapeutics Market Segmentation

Figure 2.           Multiple Sclerosis Therapeutics Market Segmentation, By Country

Figure 3.           Multiple Sclerosis Therapeutics Market Overview

Figure 4.           Immunomodulators Segment by Drug Class Held the Larger Share of Multiple Sclerosis Therapeutics Market

Figure 5.           Middle East and Africa Multiple Sclerosis Therapeutics Market – Leading Country Markets (US$ Million)

Figure 6.           Middle East and Africa (MEA) PEST Analysis

Figure 7.           Multiple Sclerosis Therapeutics Market Impact Analysis of Driver and Restraints

Figure 8.           Middle East and Africa Multiple Sclerosis Therapeutics Market – Revenue Forecast and Analysis – 2019- 2027

Figure 9.           Multiple Sclerosis Therapeutics Market Revenue Share, by Drug Class (2019 and 2027)

Figure 10.        Immunosuppressant: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Immunomodulators: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Multiple Sclerosis Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)

Figure 13.        Injectable: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Oral: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Multiple Sclerosis Therapeutics Market Share, by Distribution Channel, 2019 and 2027

Figure 16.        Hospital Pharmacies: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Retail Pharmacies: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        E-Commerce: Multiple Sclerosis Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Middle East and Africa Multiple Sclerosis Therapeutics Market Share Overview, By Country (2019)

Figure 20.        Middle East and Africa Multiple Sclerosis Therapeutics Market Share, By Country (2019 & 2027) (%)

Figure 21.        Saudi Arabia Multiple Sclerosis Therapeutic Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        South Africa Multiple Sclerosis Therapeutic Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.        UAE Multiple Sclerosis Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.        Impact of COVID-19 Pandemic in Middle East and Africa Market